Novartis' breast cancer treatment wins FDA approval
The U.S. Food and Drug Administration (FDA) said on Friday it approved Novartis AG's treatment in combination with hormone therapy fulvestrant for postmenopausal women, as well as men, with a form of advanced breast cancer.
from Reuters: Health News https://reut.rs/2WpzJk2
http://bit.ly/2zwRqiM